
Development and manufacture of non-invasive patient monitoring technologies such as SET® pulse oximetry, sensors and patient monitors
Masimo Corporation
Irvine, CA (US) · Neuchâtel (CH) · Puchheim (DE)New on Amplifa
About Masimo
Masimo (NASDAQ: MASI) is an internationally active medical technology company that develops and manufactures non-invasive monitoring technologies, including innovative measurement methods, sensors and patient monitors. Core products are SET® pulse oximetry (Signal Extraction Technology®), rainbow® Pulse CO-Oximetry, SedLine® brain function monitoring, O3® regional oximetry, LiDCO® hemodynamics as well as capnography solutions on the Root® platform. Through the Masimo Hospital Automation™ and Masimo SafetyNet® platforms, the company also offers solutions for connectivity, automation and telemonitoring. The technologies are also used via licensing agreements in devices from Philips, GE Healthcare, Mindray, Spacelabs and Zoll. Masimo was founded in 1989 by Joe Kiani and employs more than 7,000 people worldwide; the global headquarters is located in Irvine, California, and the international headquarters in Neuchâtel (Switzerland). For Germany and Austria, Masimo Deutschland GmbH in Puchheim is responsible. Since 2024/2025, Masimo has been part of Danaher.
- Site
- Puchheim
- Processes
- Technical customer service and global repair/depot network, Recycling program for pulse oximetry sensors, Telehealth/telemonitoring (Masimo SafetyNet, Hospital Automation), OEM licensing of the technologies, X-Cal calibration service
- Materials
- Signal Extraction Technology® (pulse oximetry), rainbow® Pulse CO-Oximetry, Brain Function Monitoring, Regional Oximetry, Capnography, Hemodynamic Monitoring
- Certificates
- Global Compliance Program (Code of Conduct, AdvaMed/MedTech Europe), ISO 9001
- Founded
- 1989
- Employees
- 7000+ (worldwide)
- Industries
- Medical technology, Healthcare (hospitals, ICUs, OR, neonatology), Home care, Animal health
- 01
Research and Development
- 02
Sensor and Device Development
- 03
Production
- 04
Sales and OEM Licensing
- 05
Technical Customer Service and Global Repair/Depot Network
- 06
Recycling Program for Pulse Oximetry Sensors
Technologies and Measurement Methods
Signal Extraction Technology® (pulse oximetry)
Adaptive signal processing for accurate SpO2 and pulse rate measurement during motion and low perfusion.
rainbow® Pulse CO-Oximetry
Multi-wavelength measurement of SpHb®, SpCO®, SpMet®, ORi™ and other hemoglobin-related parameters.
Brain Function Monitoring
Bilateral EEG with Patient State Index (PSi) for sedation monitoring.
Regional Oximetry
Non-invasive, continuous monitoring of oxygen saturation of cerebral and somatic tissue.
Capnography
Sidestream and mainstream capnography solutions for ventilation and gas monitoring.
Hemodynamic Monitoring
Minimally invasive beat-to-beat determination of cardiac output with PulseCO™ technology.
Locations

Irvine, CA
USGlobal Headquarters
- Solar panels at headquarters for the use of renewable energy
Neuchâtel
CHInternational Headquarters (Masimo International Sàrl)
Puchheim
DEMasimo Deutschland GmbH, sales office for Germany and Austria
Products and Sensors







Inside the production




Industries
Additional services
Reference customers
Quality and Compliance
Masimo maintains a global compliance program with a code of conduct, AdvaMed and MedTech Europe codes, and a whistleblower hotline; an Executive Vice President position is responsible for quality and regulatory affairs. Certificates such as ISO standards are not individually listed in the evaluated sources.
| Evidence | Irvine, CA | Neuchâtel | Puchheim |
|---|---|---|---|
| Global Compliance Program (Code of Conduct, AdvaMed/MedTech Europe) | |||
| ISO 9001 |
Company History
- 1989
Masimo founded by Joe Kiani as a private "garage startup"
- 1996
Introduction of Signal Extraction Technology® (SET®), the first Measure-through Motion and Low Perfusion™ pulse oximetry
- 2005
Introduction of rainbow® technology for non-invasive monitoring of additional parameters
- 2024
Masimo becomes part of Danaher